世界の呼吸器抗ウイルス剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Respiratory Antivirals Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4816
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、呼吸器抗ウイルス剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヌクレオシド類似体、ノイラミニダーゼ阻害剤、イオンチャネル遮断薬、融合タンパク質阻害剤）、用途別市場規模（上気道感染症（URTI）、インフルエンザ、細気管支炎、肺炎、はしか、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・呼吸器抗ウイルス剤の市場動向
・企業の競争状況、市場シェア
・呼吸器抗ウイルス剤の種類別市場規模と予測2016-2027（ヌクレオシド類似体、ノイラミニダーゼ阻害剤、イオンチャネル遮断薬、融合タンパク質阻害剤）
・呼吸器抗ウイルス剤の用途別市場規模と予測2016-2027（上気道感染症（URTI）、インフルエンザ、細気管支炎、肺炎、はしか、その他）
・呼吸器抗ウイルス剤の北米市場規模2016-2027（アメリカ、カナダ）
・呼吸器抗ウイルス剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・呼吸器抗ウイルス剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・呼吸器抗ウイルス剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・呼吸器抗ウイルス剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GSK、Boehringer Ingelheim、AstraZeneca、Merck、Novartis、Beximco Pharmaceuticals、Pfizer、Roche、Bristol-Myers Squibb Company、Johnson & Johnson、AbbVie Inc.、Sanofi）
・結論

Market Analysis and Insights: Global Respiratory Antivirals Market
The global Respiratory Antivirals market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Respiratory Antivirals market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Respiratory Antivirals market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Respiratory Antivirals market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Respiratory Antivirals market.

Global Respiratory Antivirals Scope and Market Size
Respiratory Antivirals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Antivirals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nucleoside Analogs
Neuraminidase Inhibitors
Ion Channel Blockers
Fusion Protein Inhibitors

Segment by Application
Upper Respiratory Tract Infections (URTIs)
Influenza
Bronchiolitis
Pneumonia
Measles
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GSK
Boehringer Ingelheim
AstraZeneca
Merck
Novartis
Beximco Pharmaceuticals
Pfizer
Roche
Bristol-Myers Squibb Company
Johnson & Johnson
AbbVie Inc.
Sanofi

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Antivirals Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nucleoside Analogs
1.2.3 Neuraminidase Inhibitors
1.2.4 Ion Channel Blockers
1.2.5 Fusion Protein Inhibitors
1.3 Market by Application
1.3.1 Global Respiratory Antivirals Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Upper Respiratory Tract Infections (URTIs)
1.3.3 Influenza
1.3.4 Bronchiolitis
1.3.5 Pneumonia
1.3.6 Measles
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Respiratory Antivirals Market Perspective (2016-2027)
2.2 Respiratory Antivirals Growth Trends by Regions
2.2.1 Respiratory Antivirals Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Respiratory Antivirals Historic Market Share by Regions (2016-2021)
2.2.3 Respiratory Antivirals Forecasted Market Size by Regions (2022-2027)
2.3 Respiratory Antivirals Industry Dynamic
2.3.1 Respiratory Antivirals Market Trends
2.3.2 Respiratory Antivirals Market Drivers
2.3.3 Respiratory Antivirals Market Challenges
2.3.4 Respiratory Antivirals Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Respiratory Antivirals Players by Revenue
3.1.1 Global Top Respiratory Antivirals Players by Revenue (2016-2021)
3.1.2 Global Respiratory Antivirals Revenue Market Share by Players (2016-2021)
3.2 Global Respiratory Antivirals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Respiratory Antivirals Revenue
3.4 Global Respiratory Antivirals Market Concentration Ratio
3.4.1 Global Respiratory Antivirals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Antivirals Revenue in 2020
3.5 Respiratory Antivirals Key Players Head office and Area Served
3.6 Key Players Respiratory Antivirals Product Solution and Service
3.7 Date of Enter into Respiratory Antivirals Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Respiratory Antivirals Breakdown Data by Type
4.1 Global Respiratory Antivirals Historic Market Size by Type (2016-2021)
4.2 Global Respiratory Antivirals Forecasted Market Size by Type (2022-2027)

5 Respiratory Antivirals Breakdown Data by Application
5.1 Global Respiratory Antivirals Historic Market Size by Application (2016-2021)
5.2 Global Respiratory Antivirals Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Respiratory Antivirals Market Size (2016-2027)
6.2 North America Respiratory Antivirals Market Size by Type
6.2.1 North America Respiratory Antivirals Market Size by Type (2016-2021)
6.2.2 North America Respiratory Antivirals Market Size by Type (2022-2027)
6.2.3 North America Respiratory Antivirals Market Size by Type (2016-2027)
6.3 North America Respiratory Antivirals Market Size by Application
6.3.1 North America Respiratory Antivirals Market Size by Application (2016-2021)
6.3.2 North America Respiratory Antivirals Market Size by Application (2022-2027)
6.3.3 North America Respiratory Antivirals Market Size by Application (2016-2027)
6.4 North America Respiratory Antivirals Market Size by Country
6.4.1 North America Respiratory Antivirals Market Size by Country (2016-2021)
6.4.2 North America Respiratory Antivirals Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Respiratory Antivirals Market Size (2016-2027)
7.2 Europe Respiratory Antivirals Market Size by Type
7.2.1 Europe Respiratory Antivirals Market Size by Type (2016-2021)
7.2.2 Europe Respiratory Antivirals Market Size by Type (2022-2027)
7.2.3 Europe Respiratory Antivirals Market Size by Type (2016-2027)
7.3 Europe Respiratory Antivirals Market Size by Application
7.3.1 Europe Respiratory Antivirals Market Size by Application (2016-2021)
7.3.2 Europe Respiratory Antivirals Market Size by Application (2022-2027)
7.3.3 Europe Respiratory Antivirals Market Size by Application (2016-2027)
7.4 Europe Respiratory Antivirals Market Size by Country
7.4.1 Europe Respiratory Antivirals Market Size by Country (2016-2021)
7.4.2 Europe Respiratory Antivirals Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Respiratory Antivirals Market Size (2016-2027)
8.2 Asia-Pacific Respiratory Antivirals Market Size by Type
8.2.1 Asia-Pacific Respiratory Antivirals Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Respiratory Antivirals Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Respiratory Antivirals Market Size by Type (2016-2027)
8.3 Asia-Pacific Respiratory Antivirals Market Size by Application
8.3.1 Asia-Pacific Respiratory Antivirals Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Respiratory Antivirals Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Respiratory Antivirals Market Size by Application (2016-2027)
8.4 Asia-Pacific Respiratory Antivirals Market Size by Region
8.4.1 Asia-Pacific Respiratory Antivirals Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Respiratory Antivirals Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Respiratory Antivirals Market Size (2016-2027)
9.2 Latin America Respiratory Antivirals Market Size by Type
9.2.1 Latin America Respiratory Antivirals Market Size by Type (2016-2021)
9.2.2 Latin America Respiratory Antivirals Market Size by Type (2022-2027)
9.2.3 Latin America Respiratory Antivirals Market Size by Type (2016-2027)
9.3 Latin America Respiratory Antivirals Market Size by Application
9.3.1 Latin America Respiratory Antivirals Market Size by Application (2016-2021)
9.3.2 Latin America Respiratory Antivirals Market Size by Application (2022-2027)
9.3.3 Latin America Respiratory Antivirals Market Size by Application (2016-2027)
9.4 Latin America Respiratory Antivirals Market Size by Country
9.4.1 Latin America Respiratory Antivirals Market Size by Country (2016-2021)
9.4.2 Latin America Respiratory Antivirals Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Respiratory Antivirals Market Size (2016-2027)
10.2 Middle East & Africa Respiratory Antivirals Market Size by Type
10.2.1 Middle East & Africa Respiratory Antivirals Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Respiratory Antivirals Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Respiratory Antivirals Market Size by Type (2016-2027)
10.3 Middle East & Africa Respiratory Antivirals Market Size by Application
10.3.1 Middle East & Africa Respiratory Antivirals Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Respiratory Antivirals Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Respiratory Antivirals Market Size by Application (2016-2027)
10.4 Middle East & Africa Respiratory Antivirals Market Size by Country
10.4.1 Middle East & Africa Respiratory Antivirals Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Respiratory Antivirals Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Respiratory Antivirals Introduction
11.1.4 GSK Revenue in Respiratory Antivirals Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Respiratory Antivirals Introduction
11.2.4 Boehringer Ingelheim Revenue in Respiratory Antivirals Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Respiratory Antivirals Introduction
11.3.4 AstraZeneca Revenue in Respiratory Antivirals Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Respiratory Antivirals Introduction
11.4.4 Merck Revenue in Respiratory Antivirals Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Respiratory Antivirals Introduction
11.5.4 Novartis Revenue in Respiratory Antivirals Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Beximco Pharmaceuticals
11.6.1 Beximco Pharmaceuticals Company Details
11.6.2 Beximco Pharmaceuticals Business Overview
11.6.3 Beximco Pharmaceuticals Respiratory Antivirals Introduction
11.6.4 Beximco Pharmaceuticals Revenue in Respiratory Antivirals Business (2016-2021)
11.6.5 Beximco Pharmaceuticals Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Respiratory Antivirals Introduction
11.7.4 Pfizer Revenue in Respiratory Antivirals Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Respiratory Antivirals Introduction
11.8.4 Roche Revenue in Respiratory Antivirals Business (2016-2021)
11.8.5 Roche Recent Development
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Details
11.9.2 Bristol-Myers Squibb Company Business Overview
11.9.3 Bristol-Myers Squibb Company Respiratory Antivirals Introduction
11.9.4 Bristol-Myers Squibb Company Revenue in Respiratory Antivirals Business (2016-2021)
11.9.5 Bristol-Myers Squibb Company Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Respiratory Antivirals Introduction
11.10.4 Johnson & Johnson Revenue in Respiratory Antivirals Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 AbbVie Inc.
11.11.1 AbbVie Inc. Company Details
11.11.2 AbbVie Inc. Business Overview
11.11.3 AbbVie Inc. Respiratory Antivirals Introduction
11.11.4 AbbVie Inc. Revenue in Respiratory Antivirals Business (2016-2021)
11.11.5 AbbVie Inc. Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Respiratory Antivirals Introduction
11.12.4 Sanofi Revenue in Respiratory Antivirals Business (2016-2021)
11.12.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Respiratory Antivirals Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nucleoside Analogs
Table 3. Key Players of Neuraminidase Inhibitors
Table 4. Key Players of Ion Channel Blockers
Table 5. Key Players of Fusion Protein Inhibitors
Table 6. Global Respiratory Antivirals Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Respiratory Antivirals Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Respiratory Antivirals Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Respiratory Antivirals Market Share by Regions (2016-2021)
Table 10. Global Respiratory Antivirals Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Respiratory Antivirals Market Share by Regions (2022-2027)
Table 12. Respiratory Antivirals Market Trends
Table 13. Respiratory Antivirals Market Drivers
Table 14. Respiratory Antivirals Market Challenges
Table 15. Respiratory Antivirals Market Restraints
Table 16. Global Respiratory Antivirals Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Respiratory Antivirals Market Share by Players (2016-2021)
Table 18. Global Top Respiratory Antivirals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Antivirals as of 2020)
Table 19. Ranking of Global Top Respiratory Antivirals Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Respiratory Antivirals Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Respiratory Antivirals Product Solution and Service
Table 23. Date of Enter into Respiratory Antivirals Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Respiratory Antivirals Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Respiratory Antivirals Revenue Market Share by Type (2016-2021)
Table 27. Global Respiratory Antivirals Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Respiratory Antivirals Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Respiratory Antivirals Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Respiratory Antivirals Revenue Market Share by Application (2016-2021)
Table 31. Global Respiratory Antivirals Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Respiratory Antivirals Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Respiratory Antivirals Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Respiratory Antivirals Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Respiratory Antivirals Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Respiratory Antivirals Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Respiratory Antivirals Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Respiratory Antivirals Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Respiratory Antivirals Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Respiratory Antivirals Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Respiratory Antivirals Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Respiratory Antivirals Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Respiratory Antivirals Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Respiratory Antivirals Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Respiratory Antivirals Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Respiratory Antivirals Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Respiratory Antivirals Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Respiratory Antivirals Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Respiratory Antivirals Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Respiratory Antivirals Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Respiratory Antivirals Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Respiratory Antivirals Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Respiratory Antivirals Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Respiratory Antivirals Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Respiratory Antivirals Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Respiratory Antivirals Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Respiratory Antivirals Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Respiratory Antivirals Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Respiratory Antivirals Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Respiratory Antivirals Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Respiratory Antivirals Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Respiratory Antivirals Market Size by Country (2022-2027) & (US$ Million)
Table 63. GSK Company Details
Table 64. GSK Business Overview
Table 65. GSK Respiratory Antivirals Product
Table 66. GSK Revenue in Respiratory Antivirals Business (2016-2021) & (US$ Million)
Table 67. GSK Recent Development
Table 68. Boehringer Ingelheim Company Details
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Respiratory Antivirals Product
Table 71. Boehringer Ingelheim Revenue in Respiratory Antivirals Business (2016-2021) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Respiratory Antivirals Product
Table 76. AstraZeneca Revenue in Respiratory Antivirals Business (2016-2021) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Respiratory Antivirals Product
Table 81. Merck Revenue in Respiratory Antivirals Business (2016-2021) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Respiratory Antivirals Product
Table 86. Novartis Revenue in Respiratory Antivirals Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Beximco Pharmaceuticals Company Details
Table 89. Beximco Pharmaceuticals Business Overview
Table 90. Beximco Pharmaceuticals Respiratory Antivirals Product
Table 91. Beximco Pharmaceuticals Revenue in Respiratory Antivirals Business (2016-2021) & (US$ Million)
Table 92. Beximco Pharmaceuticals Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Respiratory Antivirals Product
Table 96. Pfizer Revenue in Respiratory Antivirals Business (2016-2021) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Roche Company Details
Table 99. Roche Business Overview
Table 100. Roche Revenue in Respiratory Antivirals Business (2016-2021) & (US$ Million)
Table 101. Roche Recent Development
Table 102. Bristol-Myers Squibb Company Company Details
Table 103. Bristol-Myers Squibb Company Business Overview
Table 104. Bristol-Myers Squibb Company Respiratory Antivirals Product
Table 105. Bristol-Myers Squibb Company Revenue in Respiratory Antivirals Business (2016-2021) & (US$ Million)
Table 106. Bristol-Myers Squibb Company Recent Development
Table 107. Johnson & Johnson Company Details
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Respiratory Antivirals Product
Table 110. Johnson & Johnson Revenue in Respiratory Antivirals Business (2016-2021) & (US$ Million)
Table 111. Johnson & Johnson Recent Development
Table 112. AbbVie Inc. Company Details
Table 113. AbbVie Inc. Business Overview
Table 114. AbbVie Inc. Respiratory Antivirals Product
Table 115. AbbVie Inc. Revenue in Respiratory Antivirals Business (2016-2021) & (US$ Million)
Table 116. AbbVie Inc. Recent Development
Table 117. Sanofi Company Details
Table 118. Sanofi Business Overview
Table 119. Sanofi Respiratory Antivirals Product
Table 120. Sanofi Revenue in Respiratory Antivirals Business (2016-2021) & (US$ Million)
Table 121. Sanofi Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Antivirals Market Share by Type: 2020 VS 2027
Figure 2. Nucleoside Analogs Features
Figure 3. Neuraminidase Inhibitors Features
Figure 4. Ion Channel Blockers Features
Figure 5. Fusion Protein Inhibitors Features
Figure 6. Global Respiratory Antivirals Market Share by Application: 2020 VS 2027
Figure 7. Upper Respiratory Tract Infections (URTIs) Case Studies
Figure 8. Influenza Case Studies
Figure 9. Bronchiolitis Case Studies
Figure 10. Pneumonia Case Studies
Figure 11. Measles Case Studies
Figure 12. Others Case Studies
Figure 13. Respiratory Antivirals Report Years Considered
Figure 14. Global Respiratory Antivirals Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Respiratory Antivirals Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Respiratory Antivirals Market Share by Regions: 2020 VS 2027
Figure 17. Global Respiratory Antivirals Market Share by Regions (2022-2027)
Figure 18. Global Respiratory Antivirals Market Share by Players in 2020
Figure 19. Global Top Respiratory Antivirals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Antivirals as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Respiratory Antivirals Revenue in 2020
Figure 21. Global Respiratory Antivirals Revenue Market Share by Type (2016-2021)
Figure 22. Global Respiratory Antivirals Revenue Market Share by Type (2022-2027)
Figure 23. North America Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Respiratory Antivirals Market Share by Type (2016-2027)
Figure 25. North America Respiratory Antivirals Market Share by Application (2016-2027)
Figure 26. North America Respiratory Antivirals Market Share by Country (2016-2027)
Figure 27. United States Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Respiratory Antivirals Market Share by Type (2016-2027)
Figure 31. Europe Respiratory Antivirals Market Share by Application (2016-2027)
Figure 32. Europe Respiratory Antivirals Market Share by Country (2016-2027)
Figure 33. Germany Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Respiratory Antivirals Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Respiratory Antivirals Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Respiratory Antivirals Market Share by Region (2016-2027)
Figure 43. China Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Respiratory Antivirals Market Share by Type (2016-2027)
Figure 51. Latin America Respiratory Antivirals Market Share by Application (2016-2027)
Figure 52. Latin America Respiratory Antivirals Market Share by Country (2016-2027)
Figure 53. Mexico Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Respiratory Antivirals Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Respiratory Antivirals Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Respiratory Antivirals Market Share by Country (2016-2027)
Figure 59. Turkey Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Respiratory Antivirals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. GSK Revenue Growth Rate in Respiratory Antivirals Business (2016-2021)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Respiratory Antivirals Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Respiratory Antivirals Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Respiratory Antivirals Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Respiratory Antivirals Business (2016-2021)
Figure 67. Beximco Pharmaceuticals Revenue Growth Rate in Respiratory Antivirals Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Respiratory Antivirals Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Respiratory Antivirals Business (2016-2021)
Figure 70. Bristol-Myers Squibb Company Revenue Growth Rate in Respiratory Antivirals Business (2016-2021)
Figure 71. Johnson & Johnson Revenue Growth Rate in Respiratory Antivirals Business (2016-2021)
Figure 72. AbbVie Inc. Revenue Growth Rate in Respiratory Antivirals Business (2016-2021)
Figure 73. Sanofi Revenue Growth Rate in Respiratory Antivirals Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

以下、関連資料のご紹介

世界の牛用呼吸器ワクチン市場規模・現状・予測（2021年-2027年）

Global Cattle Respiratory Vaccines Market Size, Status and Forecast 2021-2027
QFJ1-3980 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、牛用呼吸器ワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（感染性ウシ鼻気管炎（IBR）ワクチン、ウシウイルス性下痢（BVD）ワクチン、パラインフルエンザ3（PI3）ワクチン、ウシ呼吸器合胞体ウ...

世界の呼吸器病原体検査市場規模・現状・予測（2021年-2027年）

Global Respiratory Pathogen Testing Market Size, Status and Forecast 2021-2027
QFJ1-4817 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、呼吸器病原体検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（細菌性呼吸器病原体検査、ウイルス性呼吸器病原体検査）、用途別市場規模（病院、クリニック、診断研究所、その他）、主要地域別市場規模（北米、...

世界の上気道感染症治療市場規模・現状・予測（2021年-2027年）

Global Upper Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6058 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、上気道感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬 (NSAIDs) ＆鼻充血除去薬、その他）、用途別市場規模（鼻炎、副鼻腔炎、鼻咽頭炎、喉頭蓋炎、喉頭炎...

世界の小児呼吸器疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Pediatric Respiratory Disease Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4675 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、小児呼吸器疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、気管支拡張薬、併用薬、コルチコステロイド、モノクローナル抗体、その他）、用途別市場規模（喘息、嚢胞性線維症、細気管支炎、肺...

世界の呼吸器抗ウイルス治療市場規模・現状・予測（2021年-2027年）

Global Respiratory Antiviral Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4815 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、呼吸器抗ウイルス治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インフルエンザ、細気管支炎、肺炎、上気道感染症（URTI）、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域...

世界の呼吸器感染症診断市場規模・現状・予測（2021年-2027年）

Global Respiratory Infection Diagnostic Market Size, Status and Forecast 2021-2027
QFJ1-5333 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、呼吸器感染症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（微生物、PCR、NGS、イムノアッセイ）、用途別市場規模（病院研究室、外来研究室）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の呼吸器合胞体ウイルス（RSV）治療薬市場規模・現状・予測（2021年-2027年）

Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5991 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、呼吸器合胞体ウイルス（RSV）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（パリビズマブ、リバビリン、その他）、用途別市場規模（病院薬局、ドラッグストア、小売薬局、その他）、主要地域別市場規模...

世界の小動物呼吸器疾患治療市場規模・現状・予測（2021年-2027年）

Global Small Animals Respiratory Diseases Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4873 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、小動物呼吸器疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（駆虫薬、非ステロイド性抗炎症薬（NSAID）、コルチコステロイド、抗生物薬、抗ヒスタミン薬、ホスホジエステラーゼ（PDE）阻害薬、気...

世界の急性呼吸窮迫症候群治療法市場規模・現状・予測（2021年-2027年）

Global Acute Respiratory Distress Syndrome Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3760 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、急性呼吸窮迫症候群治療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（メチルプレドニゾロン、ヒドロコルチゾン、注射用ウシ肺サーファクタント、その他）、用途別市場規模（入院患者、外来患者）、主要地域別...

世界の重症急性呼吸器症候群（SARS）治療薬市場規模・現状・予測（2021年-2027年）

Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4854 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、重症急性呼吸器症候群（SARS）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CEL-1000、D-3252、FDX-000、INO-4500、LCA-60、その他）、用途別市場規模（病院、ク...

世界の上気道感染症治療市場規模・現状・予測（2021年-2027年） Rhinitis, sinusitis, nasopharyngitis, epiglottitis, laryngitis, and whooping cough are some of the types of upper respiratory tract infections. It can be treated with various drugs such as azithromycin, doxycycline, xylometazoline, propylhexedrine, amoxicillin, clarithromycin, aspirin, ibuprofen, er…
世界の気道感染症（RTI）治療市場規模・現状・予測（2021年-2027年） Respiratory Infections Treatment can affect the sinuses, throat, airways or lungs. Market Analysis and Insights: Global Respiratory Tract infections (RTIs) Treatment Market The global Respiratory Tract infections (RTIs) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX …
世界の呼吸器抗ウイルス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Respiratory Antiviral Treatment Market The global Respiratory Antiviral Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年） Neuraminidase Inhibitors (NAIs) are the type of drugs that are used to block the neuraminidase enzyme. Market Analysis and Insights: Global Neuraminidase Inhibitors Drug Market The global Neuraminidase Inhibitors Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…
世界の小動物呼吸器疾患治療市場規模・現状・予測（2021年-2027年） According to veterinary medical experts, upper respiratory infections– also called canine infectious respiratory disease (CIRD) is mainly caused in spaces occupied or visited by many pets such as boarding houses, groomers, and parks. Market Analysis and Insights: Global Small Animals Respiratory Dis…